JP2013522229A5 - - Google Patents

Download PDF

Info

Publication number
JP2013522229A5
JP2013522229A5 JP2012557258A JP2012557258A JP2013522229A5 JP 2013522229 A5 JP2013522229 A5 JP 2013522229A5 JP 2012557258 A JP2012557258 A JP 2012557258A JP 2012557258 A JP2012557258 A JP 2012557258A JP 2013522229 A5 JP2013522229 A5 JP 2013522229A5
Authority
JP
Japan
Prior art keywords
composition
acyl
aryl
hydrogen
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012557258A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013522229A (ja
JP5890785B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/027984 external-priority patent/WO2011112864A1/en
Publication of JP2013522229A publication Critical patent/JP2013522229A/ja
Publication of JP2013522229A5 publication Critical patent/JP2013522229A5/ja
Application granted granted Critical
Publication of JP5890785B2 publication Critical patent/JP5890785B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012557258A 2010-03-10 2011-03-10 マクロライド抗生物質の非経口製剤 Active JP5890785B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31241710P 2010-03-10 2010-03-10
US61/312,417 2010-03-10
PCT/US2011/027984 WO2011112864A1 (en) 2010-03-10 2011-03-10 Parenteral formulations of macrolide antibiotics

Publications (3)

Publication Number Publication Date
JP2013522229A JP2013522229A (ja) 2013-06-13
JP2013522229A5 true JP2013522229A5 (https=) 2014-04-03
JP5890785B2 JP5890785B2 (ja) 2016-03-22

Family

ID=44563855

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012557258A Active JP5890785B2 (ja) 2010-03-10 2011-03-10 マクロライド抗生物質の非経口製剤

Country Status (11)

Country Link
US (3) US20130045937A1 (https=)
EP (1) EP2544537B1 (https=)
JP (1) JP5890785B2 (https=)
CN (2) CN109091489A (https=)
AU (1) AU2011224238B2 (https=)
CA (1) CA2792616A1 (https=)
DK (1) DK2544537T3 (https=)
ES (1) ES2637072T3 (https=)
PL (1) PL2544537T3 (https=)
SI (1) SI2544537T1 (https=)
WO (1) WO2011112864A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
JP5711135B2 (ja) 2008-10-24 2015-04-30 センプラ ファーマシューティカルズ,インコーポレイテッド 胃腸疾患を治療するための方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
MX361413B (es) 2010-03-22 2018-12-05 Cempra Pharmaceuticals Inc Star Formas cristalinas de un macrólido y usos para las mismas.
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
WO2013053076A1 (en) 2011-10-10 2013-04-18 Zensun (Shanghai)Science & Technology Limited Compositions and methods for treating heart failure
NZ700182A (en) * 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en) * 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法
JP6437523B2 (ja) 2013-04-04 2018-12-12 プレジデント アンド フェローズ オブ ハーバード カレッジ マクロライドならびにそれらの調製および使用の方法
EP3895724B1 (en) 2013-05-22 2025-06-25 Zensun (Shanghai) Science and Technology, Co., Ltd. Extended release of neuregulin for treating heart failure
CN110946993A (zh) 2014-01-03 2020-04-03 上海泽生科技开发股份有限公司 纽兰格林制剂的配方
SG11201700827RA (en) * 2014-08-05 2017-03-30 Cempra Pharmaceuticals Inc Powder oral suspension formulations of antibacterial agents
CN106998685A (zh) 2014-10-08 2017-08-01 哈佛大学的校长及成员们 14‑元酮内酯及其制备和使用方法
CN111407882A (zh) 2014-10-17 2020-07-14 上海泽生科技开发股份有限公司 神经调节蛋白用于预防、治疗或延迟射血分数保留的心力衰竭的方法和组合物
EP3273969A4 (en) 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides with modified desosamine sugars and uses thereof
BR112021026480A2 (pt) * 2019-06-28 2022-02-08 Univ Texas Método para reconstituir anamicina, método para preparar uma dose eficaz de uma formulação lipossômica reconstituída de anamicina e método para tratar câncer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
NZ523693A (en) * 2000-07-10 2004-08-27 Chiron Corp Macrolide formulations for inhalation and methods of treatment of endobronchial infections
BR0307898A (pt) * 2002-02-22 2004-12-07 Pharmacia Corp Formulações de droga antibiótica oftálmica contendo um composto de ciclodextrina e cloreto de cetil piridìnio
EP1638549A4 (en) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
CN101045063B (zh) * 2006-03-28 2011-01-26 广州朗圣药业有限公司 注射用克拉霉素水溶性制剂
CN101129383B (zh) * 2006-08-25 2014-04-02 天津和美生物技术有限公司 含氨基糖苷类抗生素的抗生素复方

Similar Documents

Publication Publication Date Title
JP2013522229A5 (https=)
JP2013528600A5 (https=)
JP2013542247A5 (https=)
WO2012142093A3 (en) 2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
MX2010007374A (es) Nuevos derivados de c-21-ceto lupano, preparacion y uso de los mismos.
MX2010006209A (es) Derivados de quinoxalinilo.
NZ703564A (en) Oral formulations and lipophilic salts of methylnaltrexone
JP2015537020A5 (https=)
MX2010007375A (es) Nuevos derivados de lupano.
JP2010505865A5 (https=)
WO2012116290A3 (en) Neuroactive 17(20)-z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
WO2008054454A3 (en) Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
EA200870423A1 (ru) Производные триазолпиразинов, применимые в качестве противораковых агентов
BR112015029491A2 (pt) derivados de imidazopirrolidinona e seu uso no tratamento de doença
JP2013532729A5 (https=)
JP2011502997A5 (https=)
WO2009076166A3 (en) Oximyl hcv serine protease inhibitors
JP2013500977A5 (https=)
WO2013059278A3 (en) Hepatitis c virus inhibitors
JP2015522033A5 (https=)
JP2015521617A5 (https=)
JP2013519653A5 (https=)
WO2011128407A3 (en) Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations
WO2021055425A3 (en) Functionalized heterocycles as antiviral agents